Using hydrogen sulfide to design and develop drugs
| Autor: | Maria Cristina Breschi, Valentina Citi, Lara Testai, Alma Martelli, Vincenzo Calderone |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
H2S-releasing drug discovery
gasotransmitters Pharmacology 0301 basic medicine Drug discovery Chemistry Hydrogen sulfide Nanotechnology equipment and supplies Combinatorial chemistry 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology H2S-donors Drug Design Drug Discovery Animals Humans Hydrogen Sulfide Gasotransmitters |
| Zdroj: | Expert Opinion on Drug Discovery. 11:163-175 |
| ISSN: | 1746-045X 1746-0441 |
| Popis: | Hydrogen sulfide (H2S) is an endogenous gasotransmitter, involved in the regulation of several biological functions. Conversely, impaired biosynthesis of H2S is associated with important diseases. This paves the way for exciting pharmacological perspectives for drugs acting on the 'H2S system'.At the beginning of this manuscript, the authors present the biological roles and mechanisms of action of hydrogen sulfide. The authors then discuss the developments in the modulation of the H2S system via heterogeneous molecules, which behave as sources of exogenous H2S, and are promising drugs for a number of diseases.The rate of H2S generation, the physicochemical characteristics and the bioavailability greatly affect the overall pharmacological profile of each H2S-releasing compound. Therefore, the development of broad collections of original moieties endowed with heterogeneous rates/mechanisms of H2S release and a variety of physicochemical, biological and pharmacological features is the most timely and compelling issue in the field of H2S-based drug discovery. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|